TP53 and cancer: In the proposed model based on the presented results, p53 and MYCN induce PRIMA-1MET resistance in an indirect manner, via GSH modulation, rather than via direct binding between PRIMA-1MET and p53, which is the currently held view in many other cancer models (Fig. 6c).